Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

74.05
-0.1900-0.26%
Post-market: 74.500.4500+0.61%17:26 EDT
Volume:587.23K
Turnover:43.47M
Market Cap:3.25B
PE:-68.41
High:75.08
Open:73.86
Low:73.52
Close:74.24
52wk High:85.25
52wk Low:48.20
Shares:43.88M
Float Shares:32.68M
Volume Ratio:0.88
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.37
PE(LYR):-46.57

Loading ...

Nov 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Major Issues Report

Form 8-K - Current report
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans